Blueprint Medicines
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Employees
- 655
- Market Cap
- $5.8B
- Introduction
Blueprint Medicines Corp. is a precision therapy company, which engages in the invention of medicines for people with cancer and blood disorders. The company was founded by Chris Varma, Nicholas B. Lydon, Brian Druker, and Alexis Borisy on October 14, 2008 and is headquartered in Cambridge, MA.
Two decades of advances in clinical oncology — lessons learned and future directions
S.B., A.D., T.J.F., I.M.G., L.G., R.K.J., G.K., J.M.L., G.V.L., K.P.-J., H.I.S., J.T., R.R.W., M.W., Y.L.W. have disclosed various financial interests, including funding, advisory roles, patents, and equity. C.M.B., E.B., M.W.B., and K.P. declare no competing interests.
CSF1R Inhibition in Patients with Advanced Solid Tumors or Tenosynovial Giant Cell Tumor
Various researchers report financial relationships with pharmaceutical companies, including Deciphera, during and outside the conduct of the study.
© Copyright 2024. All Rights Reserved by MedPath